PD1– CD39+ and PDhi populations had up to 2.5-fold greater response to leukemia blasts compared to the irrelevant control, as shown by 4-1BB upregulation and increased IFN-γ secretion (Fig. 3B–E, Supplementary Fig. 8). This evidence concerns the gene ENTPD1 and leukemia.